POSACONAZOLE AS PRIMARY PROPHYLAXIS REDUCES INVASIVE FUNGAL INFECTIONS IN AML PATIENTS: A SINGLE CENTRE MATCHED PAIRED ANALYSIS

被引：0
|
作者：
Minetto, P. [1 ]
Guolo, F. [1 ]
Pastori, G. [1 ]
Giannoni, L. [1 ]
Guardo, D. [1 ]
Avenoso, D. [1 ]
Clavio, M. [1 ]
Miglino, M. [1 ]
Lemoli, R. M. [1 ]
Gobbi, M. [1 ]
机构：
[1] Univ Genoa, Chair Hematol, Dept Internal Med DiMI, IRCSS AOU San Martino IST, Genoa, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1813
引用
收藏
页码：717 / 718
页数：2
相关论文
共 50 条
  • [21] PHARMACOECONOMIC ANALYSIS OF THE USE OF VORICONAZOLE, POSACONAZOLE AND MICAFUNGIN IN THE PRIMARY PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTS IN SPAIN
    Grau, S.
    Solano, C.
    Garcia Vidal, C.
    Jarque, I
    Barrueta, J.
    Peral, C.
    Rodriguez, I
    Rubio Rodriguez, D.
    Rubio-Terres, C.
    VALUE IN HEALTH, 2015, 18 (07) : A581 - A581
  • [22] A single centre experience of treatment outcomes during three antimycotic prophylaxis periods in patients with AML: Itraconazole versus posaconazole versus no prophylaxis
    Hahn-Ast, C.
    Glasmacher, A.
    Mueckter, S.
    Landwehr, C.
    Schmitz, A.
    Mayer, K.
    Marklein, G.
    Brossart, P.
    von Lilienfeld-Toal, M.
    ONKOLOGIE, 2011, 34 : 256 - 256
  • [23] A Single-Centre Experience with the Use of Posaconazole for Invasive Fungal Infections in Lung and Heart-Lung Transplant Recipients
    Ng, B. J. H.
    Hopkins, P. M. A.
    Kermeen, F. D.
    Chambers, D. C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S17 - S17
  • [24] Experience in pharmacokinetic monitoring of posaconazole as prophylaxis of invasive fungal infection in hematological patients
    Pena-Lorenzo, D.
    Rebollo, N.
    Sanchez-Hernandez, J. G.
    Zarzuelo-Castaneda, A.
    Perez-Blanco, S.
    Garcia-Casanueva, J. C.
    Vazquez-Lopez, L.
    Otero, M. J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1537 - 1537
  • [25] REDUCTION OF INVASIVE FUNGAL INFECTION (IFI) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) UNDERGOIG INDUCTION CHEMOTHERAPY WITH POSACONAZOLE FOR ANTIFUNGAL PROPHYLAXIS
    Audisio, E.
    Busca, A.
    D'Ardia, S.
    Vitolo, U.
    Marmont, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 725 - 725
  • [26] Results from an observational study on primary prophylaxis of invasive fungal disease with posaconazole in patients with acute myelogenous leukemia
    Egerer, G.
    Harter, C.
    Gaul, S.
    Schmitt, T.
    Ehlken, B.
    Silberbach, K.
    Ho, A. D.
    ONKOLOGIE, 2010, 33 : 69 - 69
  • [27] Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
    Pomares, Helena
    Arnan, Montserrat
    Sanchez-Ortega, Isabel
    Sureda, Anna
    Duarte, Rafael F.
    MYCOSES, 2016, 59 (08) : 516 - 519
  • [28] Incidence and mortality of invasive fungal infections in high-risk patients receiving posaconazole versus fluconazole or itraconazole prophylaxis
    Langston, A.
    Lipton, J. H.
    Comely, O. A.
    Ullnumn, A. J.
    Patino, H.
    Hardalo, C.
    Winston, D. J.
    Chandnisekar, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 33 - 33
  • [29] COST-EFFECTIVENESS OF POSACONAZOLE VERSUS FLUCONAZOLE OR ITRACONAZOLE IN THE PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS AMONG NEUTROPENIC PATIENTS IN THAILAND
    Junjarunee, S.
    Numuang, K.
    Lerdlitruangsin, S.
    Itzler, R.
    VALUE IN HEALTH, 2014, 17 (07) : A806 - A806
  • [30] Posaconazole for Primary Antifungal Prophylaxis in AML Patients: A Real Life Single Center Experience and a Comparison with the Historical Cohort
    Minetto, Paola
    Guolo, Fabio
    Mikulska, Malgorzata
    Pastori, Giordana
    Giannoni, Livia
    Furfaro, Elisa
    Miletich, Franca
    Del Bono, Valerio
    Ballerini, Filippo
    Clavio, Marino
    Miglino, Maurizio
    Lemoli, Roberto
    Viscoli, Claudio
    Gobbi, Marco
    BLOOD, 2014, 124 (21)
12345